GlobeNewsWire
24 Sept 2026, 22:51 UTC · 1h ago
Verdict
Headline takes no side. We score ALMR +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
A Lancet Neurology study using Alamar's NULISAseq CNS 120 panel found that plasma biomarkers for amyloid clearance differ from those associated with cognitive decline in lecanemab patients.
Newpress release dated Sept. 24, 2026
So whatThis validates the commercial utility of the 130-protein panel for pharmaceutical companion diagnostics, potentially expanding Alamar's revenue streams in FY2027.
More positive than 93% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
The study utilized Alamar's technology to profile 2,385 samples from 1,967 participants using only 25 microliters of plasma per sample.
Newpress release dated Sept. 24, 2026
More positive than 78% of claims this week
Among 197 patients treated with lecanemab, 34 of the 130 biomarkers measured showed significant changes relative to the number of infusions received.
Newpress release dated Sept. 24, 2026
More positive than 64% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company's technology was used in a published study in The Lancet Neurology to successfully reveal divergent biological responses in Alzheimer's patients.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
6h ago
—
ALMR hasn't traded since this ran. Last close $33.20 (Sep 24); the reaction starts at the next open.
ALMR chart →
